This study aims to evaluate the diagnostic efficacy, therapeutic assessment, prognostic analysis, and impact on clinical treatment decisions of 18F-FAPI PET/CT in patients with cancer of unknown primary.
Eligibility
Sex
ALL
Min age
20 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria:
1. Patients with clinical or imaging suspicion of cancer of unknown primary origin.
2. Patients with 18F FAPI PET scans.
Exclusion Criteria:
1. Concurrent presence of other active malignant tumors or a history of other malignant tumors within the past 5 years;
2. Severe uncontrollable diseases or active infections;
3. Ineligible participants for project informed consent.
4. Pregnant and lactating women.
Primary outcome measure(s)
Diagnostic efficacy — through study completion, an average of 1.5 year Sensitivity, specificity, positive and negative predictive value of 18F-FAPI PET/CT Imaging in cancers of unknown primary site
Trial sites (1)
Facility
City
Region
Status
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou
Zhejiang
More First Affiliated Hospital of Zhejiang University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.